Extracorporeal photochemotherapy--the Columbia Presbyterian experience

Area of Science:

• Oncology
• Dermatology
• Immunology

Background:

• Cutaneous T Cell Lymphoma (CTCL) is a skin-homing lymphoma primarily affecting CD4+ lymphocytes.
• Various treatments exist for CTCL, with extracorporeal photochemotherapy (ECP) being a recognized option.
• This study reviews ECP treatment outcomes for 20 CTCL patients over seven years.

Purpose of the Study:

• To evaluate the effectiveness of extracorporeal photochemotherapy (ECP) in treating Cutaneous T Cell Lymphoma (CTCL).
• To identify potential predictors of treatment response in CTCL patients undergoing ECP.

Main Methods:

• Retrospective chart review of 20 CTCL patients treated with ECP.
• Analysis of demographic characteristics, treatment response (complete, partial, stable, progressive), and prognostic variables.
• Evaluation of CD4:CD8 ratio, LDH levels, and erythrodermic status as predictors of response using Mantel-Haenszel chi-square tests.

Main Results:

• A significant association was found between response to ECP and a CD4:CD8 ratio below 10.
• Patients with normal LDH levels showed a better response to ECP compared to those with elevated levels.
• Erythrodermic status suggested a positive association with response, though not statistically significant; most erythrodermic patients responded.

Conclusions:

• Erythroderma, a lower CD4:CD8 ratio, and normal LDH are potential indicators of a favorable response to ECP in CTCL patients.
• CTCL patients presenting with erythroderma and a relatively intact immune system appear to be optimal candidates for ECP.
• ECP was generally well-tolerated with minimal side effects in this patient cohort.